Methylprednisolone Sopharma (Methylprednisolone)

Methylprednisolone acts on inflammatory and immune pathways to control a range of acute and chronic conditions.

• Acute asthma or COPD exacerbation: reduces airway inflammation and improves breathing.
• Severe allergic reactions (anaphylaxis, angioedema): rapidly suppresses hypersensitivity responses.
• Rheumatic and musculoskeletal disorders (rheumatoid arthritis, lupus): decreases joint inflammation and pain.
• Dermatologic conditions (severe eczema, psoriasis): limits skin inflammation and lesion formation.
• Neurological disorders (multiple sclerosis relapses): dampens immune‑mediated nerve inflammation.
• Prevention of organ transplant rejection: inhibits immune activation that could damage the transplanted organ.

• Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced leukocyte migration, decreased capillary permeability, and overall suppression of immune responses.

Methylprednisolone may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Hyperglycemia: elevated blood sugar levels, especially in diabetic patients.
• Fluid retention: swelling of the lower extremities or face.
• Mood changes: irritability, anxiety, or insomnia.
• Increased appetite and weight gain.
• Gastrointestinal discomfort: nausea or abdominal pain.
• Skin thinning or easy bruising.

Serious or Rare Side Effects

• Severe infection: heightened risk due to immune suppression.
• Adrenal insufficiency: reduced endogenous cortisol production.
• Cushingoid appearance: moon face, central obesity.
• Osteoporosis: decreased bone mineral density.
• Psychosis or severe mood disorders.
• Anaphylaxis: rare but potentially life‑threatening allergic reaction.

Before initiating therapy, evaluate patient history and monitor for potential complications.

• Assess infection risk: screen for active infections and treat before use.
• Monitor blood glucose: adjust antidiabetic therapy as needed.
• Evaluate bone health: consider calcium and vitamin D supplementation for long‑term use.
• Use lowest effective dose: limit duration to reduce systemic exposure.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methylprednisolone can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase steroid levels.
• Live vaccines: risk of uncontrolled infection due to immunosuppression.
• Systemic antifungals (e.g., itraconazole): can raise plasma concentrations.
• Other immunosuppressants (e.g., cyclosporine): additive immunosuppression.
• High‑dose NSAIDs: increase risk of gastrointestinal bleeding.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance fluid loss and electrolyte disturbances.
• Antidiabetic agents: steroids can raise glucose, requiring dose adjustment.
• Antihypertensives: possible reduction in blood pressure control.
• Anticoagulants: potential for altered clotting parameters.
• Vaccines (non‑live): monitor immune response efficacy.